|
Federal
Register Notices > Notices of
Registration - 2006
>Orasure Technologies, Inc
FR Doc E6-20744 [Federal Register: December 7, 2006 (Volume 71, Number 235)]
[Notices] [Page 70987] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07de06-81]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated July 26, 2006, and published in the Federal Register on
August 2, 2006, (71 FR 43814), Orasure Technologies, Inc., Lehigh University,
Seeley G. Mudd-Building 6, Bethlehem, Pennsylvania 18015, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in schedules I
and II:
|
Drug
|
Schedule
|
|
Lysergic acid diethylamide (LSD) (7315)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Normorphine (9313)
|
I
|
|
Tetrahydrocannabinols (THC) (7370)
|
I
|
|
Alphamethadol (9605)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Cocaine (9041)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Morphine (9300)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Meperidine (9230)
|
II
|
|
Methadone (9250)
|
II
|
|
Oxymorphone (9652)
|
II
|
The company plans to manufacture the listed controlled substances in bulk to
manufacture controlled substance derivatives. These derivatives will be used in
diagnostic products created specifically for internal use only.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Orasure
Technologies, Inc. to manufacture the listed basic classes of controlled
substances is consistent with the public interest at this time. DEA has
investigated Orasure Technologies, Inc. to ensure that the company's
registration is consistent with the public interest. The investigation has
included inspection and testing of the company's physical security systems,
verification of the company's compliance with State and local laws, and a review
of the company's background and history. Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR
1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled
substances listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E6-20744 Filed 12-6-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
